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Abstract
The aim of the present study was to evaluate, by heart rate variability (HRV) with 24-hours ECG
Holter (HRV), the circadian autonomic activity in offspring of type 2 diabetic subjects and the
relation with insulin-resistance. METHODS: 50 Caucasian offsprings of type 2 diabetic subjects
were divided in two groups: insulin-resistant offsprings (IR) and non insulin-resistant offsprings
(NIR). Autonomic nervous activity was studied by HRV. Time domain and spectral analysis (low
frequency, LF, and high frequency, HF, provide markers of sympathetic and parasympathetic
modulation when assessed in normalized units) were evaluated. RESULTS. Time domain showed a
reduction of total SDNN in IR (p < 0.001) and NIR (p 0.047) versus controls. Spectral analysis
showed a total and night LF higher in IR and NIR than in control group (all p < 0.001).
CONCLUSION. In frequency domain, the analysis of sympathetic (LF) and parasympathetic (HF)
component evidenced an association between the offspring of type 2 diabetic subjects and a
sympathetic overactivity. A global reduction and alteration of circadian rhythm of autonomic
activity are present in offspring of type 2 diabetic patients with and without insulin resistance. The
data of our study suggested that an autonomic impairment is associated with the familiarity for type
2 diabetes independently to insulin resistance and that an impairment of autonomic system activity
could precede the insulin resistance.
Background
Sympathetic and parasympathetic components of neu-
rovegetative system regulate cardiac activity. Spectral anal-
ysis of heart rate variability (HRV) is a non invasive
metodic used to assess cardiac autonomic activity. The
autonomic activities can be assessed in HRV by the rela-
tive distribution (evaluated in normalized units) of low
frequency (LF), as an index of sympathetic modulation
and of high frequency (HF), as an index of parasympa-
thetic modulation. The analysis of HRV has been used for
evaluate the autonomic cardiac activity in numerous
pathophisyologic conditions [1-9]: an impaired heart rate
variation is a marker of autonomic neuropathy [10,11] as
in diabetic subjects [12-16].
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Several studies have showed a sympathetic overactivity
also in non diabetic insulin resistant group [17-19]. How-
ever, little is known about the association between the
familiarity for type 2 diabetes mellitus and the autonomic
activity. An increased LF/ HF ratio (low frequency/high
frequency ratio) has identified in only insulin resistant
offsprings of type 2 diabetic subjects [20]. De Angelis et al
[21] has showed this condition at rest but not under stim-
ulated conditions. Laitinen et al [22] has identified a sym-
pathetic overactivity during acute hyperinsulinemia both
in insulin resistant and non insulin resistant offsprings of
type 2 diabetic subjects.
The aim of the present study was to evaluate, by heart rate
variability with 24-hours ECG Holter registration, the
autonomic activity and circadian autonomic rhythm in
offspring of type 2 diabetic subjects and to evaluate the
possible impact of sympathetic activity on insulin resist-
ance. We tested the hypothesis that in non insulin resist-
ant offsprings of type 2 diabetic subjects an alteration of
circadian rhythm of autonomic activity are present and
that the impairment of autonomic system activity could
precede the insulin resistance.
Subjects and methods
70 consecutive caucasian offsprings of type 2 diabetic sub-
jects, admitted to our department, were screened. In all
subjects, after an overnight fast, oral glucose tolerance
tests (OGTTs) was performed: samples blood for glucose
and plasma insulin were collected before and 2 h after a
glucose load consisting of 75 g glucose anhydrate in 300
ml of water ingested over the course of 5 min. Also, fasting
plasma insulin was measured to evaluate the insulin-
resistance by the homeostasis model assessment-index
(HOMA-I). Among them, 50 caucasian subjects (age:
47.71 ± 9.96 years, 32 men and 18 women), with normal
OGTTs, were admitted in this study and were divided in
two groups: offsprings with insulin resistance and off-
springs without insulin resistance:
Subjects with hypertension [23], diabetes mellitus,
impaired fasting glycemia, impaired glucose tolerance
[24], obesity, dyslipidemia, cardiac arrhythmias, micro-
albuminuria and with drug treatment or diseases that
could potentially disturbs carbohydrate metabolism (glu-
cocorticoids, furosemide, beta-blockers, etc.) and cardiac
autonomic activity (beta-blockers, anti-arrhythmics, ACE-
inhibitors) were excluded.
The control group consisted of 25 sex and age matched
healthy non insulin resistant subjects with normal OGTTs
and without familiarity for type 2 diabetes mellitus.
Height, weight and body circumferences were measured
on all subjects. Body mass index (BMI, kg/m2) was calcu-
lated as weight divided by height squared. Waist-to-hip
ratio (WHR) was defined as waist circumference divided
by hip circumference.
Informed consent was obtained from all participants; all
the investigations were performed in accordance with the
participants of the Declaration of Helsinki.
Insulin resistance
The insulin-resistance was evaluated by the homeostasis
model assessment index (HOMA-I) [25-28]. The HOMA-
I was calculated by the formula: fasting plasma glucose
(mmol/L) x fasting plasma insulin (µU/ml)/ 22,5, as
described by Matthews and coworkers [29]. Insulin-resist-
ance was defined as the third and fourth quartiles of
HOMA-I.
Table 1: Clinical characteristics for each study-group of offsprings and controls.
IR NIR Controls p Value
Sex (M/F) 16/9 18/7 16/9
Age (years) 49,12 ± 6,68 49,80 ± 6,53 53,69 ± 3,72 0,190
BMI (kg/m2) 25.41 ± 4.67 25.50 ± 3.69 25.09 ± 2.23 0,120
Glycemia '0 (mg/dl) 93,375 ± 11,06 99,66 ± 1,30 94,00 ± 6,15 0,095
Glycemia '120 (mg/dl) 97,62 ± 17,45 90,00 ± 26,60 92,66 ± 18,22 0,095
Fasting plasma insulin (uU/ml) 17,95 ± 6,35 7,66 ± 0,50 7,16 ± 0,21 0,000
HOMA index 4,41 ± 0,80 1.83 ± 0,12 1,45 ± 0,25
SP (mmHg) 123,20 ± 3,70 122,60± 6,35 120.20 ± 7.09 0,013
DP(mmHg) 80,00 ± 3,16 79,80± 3,56 78.80 ± 4.90 0,014
HR (bpm) 74.75 ± 4.57 70.25 ± 4.11 68.50 ± 5.92 0,011
SP: systolic pressure, DP: diastolic pressure, HR: heart rate, BMI: body mass index, HOMA-I: the homeostasis model assessment-index, IR: insulin 
resistant offsprings of type 2 diabetic patients, NIR: non insulin resistant offsprings of type 2 diabetic patients.Cardiovascular Diabetology 2005, 4:15 http://www.cardiab.com/content/4/1/15
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The index subject were subdivide into two groups based
on HOMA-I: 1) group of insulin-resistant offsprings (IR);
2) group of non insulin-resistant offsprings (NIR).
HRV assessment
Autonomic nervous activity was evaluated by heart rate
variability (HRV) analysis during 24-hour ECG recording.
All Holter recordings were performed using a three-chan-
nel recorder. Autonomic nervous activity was analysed
following the recommendations of the Task Force of the
European Society of Cardiology and the North American
Society of Pacing and Electrophysiology [30]. Spectral
estimates of R-R interval were obtained from stationary
regions free of ectopic beats and technical artefacts. The
standard deviation of normal-to-normal RR intervals
(SDNN) (ms) and the square root of the mean of the sum
of the squares of differences between adjacent NN inter-
vals (RMS-SD), correlated with parasympathetic system,
were calculated and were divided in two periods: night (0
am – 6 am) and day (7 am – 9 pm). Fast Fourier Trans-
form was used to obtain power spectral estimates of HRV.
Total power in the frequency range (0 – 0.40 Hz) was
divided into low frequency (LF: 0.04 – 0.15 Hz, modu-
lated by sympathetic system) and high frequency (HF:
0.15 – 0.40 Hz, modulated by parasympathetic system).
The power of LF and HF components was considered in
normalized units (n.u.). Subjects were analysed for 24
hours, at 10 minutes interval. Artificial data and arrhyth-
mic were excluded. The day was divided in four periods:
night (0 am – 6 am), morning (7 am – 12 am), afternoon
(1 pm – 6 pm), evening (7 pm – 11 pm). Data analyses
were performed with software Del Mar Avionics Accuplus
363, Irvine California, USA.
Statistical analysis
All analysis were done with SPSS 12.0 (SPSS Inc., Chicago,
IL, USA) for Windows XP. Data are presented as means +
SD. For data with multiple time points, variables were
analysed by the general linear model ANOVA and simple
regression analyses were carried out by standard tech-
niques 95% confidence intervals (CT) were calculated for
regression coefficient. Means values were considered sig-
nificant at p < 0.05.
Results
Clinical characteristics
The groups had not statistically significant difference in
age, sex and anthropometrics parameters (i.e. BMI, waist
and hip circumference, waist to hip ratio, table 1).
Heart rate variability
Tables 2 and 3 show the means of autonomic function
measures for each group.
Time domain
Time domain analysis of HRV showed a reduction statis-
tically significant of total SDNN in IR (p < 0.001) and NIR
(p 0.047) groups (IR: 86.10 ± 35.96 ms, NIR: 119.70 ±
28.22 ms) versus control group (131.90 ± 29.52 ms) (fig.
1). Total SDNN were reduced in IR group when compared
with (NIR) NIR group (p 0.003). These results showed a
total activity reduction of autonomic system in insulin
resistant and non insulin resistant offsprings of type 2 dia-
betic patients. The autonomic activity reduction is major
in IR group than NIR group.
RMS-SD in night time not increased in IR group. Therefore
insulin-resistance was associated with alteration of
circadian rhythm of parasympathetic component (at the
night).
Frequency domain
Frequency domain analysis of HRV showed a total LF
higher (all p < 0.001) in IR (70.88 ± 6.2 n.u.) and NIR
(67.59 ± 4.46 n.u.) groups than in control group (55.46 ±
7.49 n.u.). No difference was noticed between IR and NIR
groups (p: 0.157). HF were lower in IR (23.63 ± 6.67 n.u)
and NIR (27.09 ± 3.74 n.u.) than in control group (37.65
± 7.53) (all p < 0.001), while not statistically significant
difference were between the groups of offsprings type 2
diabetic patients, p: 0.127. LF/HF total is higher in IR
(3.34 ± 1.37) and NIR (3.72 ± 0.72) groups versus control
group (2.44 ± 1.09), respectively p 0.016 and p 0.002.
Night (0 am – 6 am)
LF value are higher in IR (67.80 ± 9.70 n.u.) and NIR
(59.60 ± 1.75 n.u.) groups than in control groups (35.21
Table 2: Means (95%CI) RR intervals in the different time periods for each offspring group and controls.
R-R (msec) IR NIR Controls
Night (0–6 am) 895,39 (821,61–969,17) 873,36 (781,09–965,64) 1126,75 (1060,44–1193,05)
morning (7–12 am) 792,44 (741,58–843,29) 752,26 (719,55–784,98) 870,29 (805,43–935,15)
afternoon (1–6 pm) 690,28 (658,75–721,82) 689,16 (638,25–740,07) 749,54 (615,63–883,46)
evening (7–11 pm) 734,37705,02–763,72) 596,87 (360,36–833,39) 910,82 (808,78–1012,87)
Value are means (95% CI), IR: insulin resistant offsprings of type 2 diabetic patients, NIR: non insulin resistant offsprings of type 2 diabetic patients, 
RR: normal-to-normal R-R interval (ms)Cardiovascular Diabetology 2005, 4:15 http://www.cardiab.com/content/4/1/15
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± 5.97) (all p < 0.001) and are higher in IR group when
compared with NIR group, p 0.001). HF are lower in IR
(25.72 ± 8.19 n.u.) and NIR group (36.53 ± 3.17) than in
control groups (58.62 ± 6.59) (all p < 0.001 vs controls).
Morning (7 am – 12 am)
LF and HF had not statistically difference between IR (LF:
73.45 ± 9.61 n.u.; HF n.u.: 22.12 ± 7.17 n.u.), NIR (LF:
69.04 ± 7.41 n.u.; HF: 24.30 ± 8.52 n.u) and control
groups (LF: 69.54 ± 8.36 n.u.; HF: 23.05 ± 7.13 n.u.).
Afternoon (1 pm – 6 pm)
LF, HF and LF/HF had not statistically difference between
IR (LF: 70.59 ± 10.62 n.u.; HF: 23.21 ± 10.25 n.u.; LF/HF:
4.65 ± 1.71), NIR (LF: 70.06 ± 4.26 n.u.; HF: 21.42 ± 3.79
n.u.; LF/HF: 3.74 ± 0.46) and control groups (LF: 70.09 ±
6.62 n.u.; HF: 22.30 ± 5.09 n.u.; LF/HF: 3.67 ± 1.30).
Evening (7 pm – 11 pm)
LF were higher in IR (71.90 ± 10.70 n.u.) and NIR (71.90
± 10.70 n.u.) groups than control group (56.75 ± 7.75
n.u.) (all p < 0.001). HF were lower in IR (23.52 ± 6.28
n.u.) and NIR (24.28 ± 9.08 n.u.) groups than control
group (35.75 ± 9.14 n.u.), respectively p: 0.001 and p:
Table 3: Autonomic function measures for each offspring group and controls.
IR NIR Controls P value
SDNN (msec) 86.10 ± 35.96 119.70 ± 28.22 131.90 ± 29.52 0,000
SDNN day (msec) 105.21 ± 28.37 128.77 ± 30.60 120.29 ± 26.97 0,062
SDNN night (msec) 118.99 ± 46.16 112.40 ± 7.54 119.57 ± 38.25 0,822
RMS-SD (msec) 43.15 ± 20.60 42.63 ± 9.18 36.75 ± 10.59 0,331
RMS-SD day (msec) 41.58 ± 18.64 34.77 ± 5.75 31.37 ± 9.07 0,050
RMS-SD night (msec) 47.47 ± 28.80 55.70 ± 18.46 47.47 ± 10.60 0,485
LF u.n. 70.88 ± 6.20 67.59 ± 4.46 55.46 ± 7.49 0,000
HF u.n. 23.63 ± 6.67 27.09 ± 3.74 37.65 ± 7.53 0,000
LF/HF 3.34 ± 1.37 3.72 ± 0.72 2.44 ± 1.09 0,004
LF night u.n. 3.34 ± 1.37 3.72 ± 0.72 2.44 ± 1.09 0,000
HF night u.n. 25.72 ± 8.19 36.53 ± 3.17 58.62 ± 6.59 0,000
LF/HF night 3.06 ± 1.49 2.21 ± 0.54 0.79 ± 0.48 0,000
LF u.n. morning 73.45 ± 9.61 69.04 ± 7.41 69.54 ± 8.36 0,298
HF u.n. morning 22.12 ± 7.17 24.30 ± 8.52 23.05 ± 7.13 0,765
LF/HF morning 4.15 ± 2.80 5.69 ± 3.11 3.70 ± 1.72 0,122
LF u.n. afternoon 70.59 ± 10.62 70.06 ± 4.26 70.09 ± 6.62 0,979
HF u.n. afternoon 23.21 ± 10.25 21.42 ± 3.79 22.30 ± 5.09 0,794
LF/HF afternoon 4.65 ± 1.71 3.74 ± 0.46 3.67 ± 1.30 0,647
LF u.n. evening 71.90 ± 10.70 71.90 ± 10.70 56.75 ± 7.75 0,000
HF u.n. evening 23.52 ± 6.28 24.28 ± 9.08 35.75 ± 9.14 0,001
LF/HF evening 3.30 ± 1.00 4.12 ± 2.21 2.00 ± 0.88 0,009
Value are means ± SD, IR: insulin resistant offsprings of type 2 diabetic patients, NIR: non insulin resistant offsprings of type 2 diabetic patients, 
SDNN: standard deviation of all sinus rhytm RR intervals, RMS SD: the square root of the mean of the sum of the squares of differencies between 
adjacent NN intervals, LF: low frequence, HF: high frequence, hours of Holter registration: night time = 0–6 am, morning = 7–12 am, afternoon = 
1–6 pm, evening = 7–11 pm. P Value is between groups.
SDNN value in offsprings of type 2 diabetic patients and  controls Figure 1
SDNN value in offsprings of type 2 diabetic patients 
and controls. SDNN: standard deviation of all sinus rhythm 
RR intervals, IR: insulin resistant offsprings of type 2 diabetic 
patients, NIR: non insulin resistant offsprings of type 2 dia-
betic patients. #p:0.003IR vs NIR; *p:0.047 controls vs NIR 
and † p:0.001 controls vs IR
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0.002. LF/HF is higher in IR (3.30 ± 1.00) and NIR (4.12
± 2.21) groups than control group (2.00 ± 0.88) (respec-
tively p: 0.04 and p: 0.002).
Discussion
The data of our study suggested that an autonomic impair-
ment is associated with the familiarity for type 2 diabetes
independently of insulin resistance. In frequency domain,
the analysis of sympathetic (LF) and parasympathetic
(HF) component and the symphatovagal balance (LF/HF)
evidenced an association between the familiarity and a
sympathetic overactivity, especially in nocturnal period,
demonstrated by increase of LF (figure 2 and figure 3) and
LF/HF ratio (figure 4). This autonomic impairment is
major in insulin resistant offsprings than non insulin
resistant offsprings of type 2 diabetic patients. Moreover,
our study had demonstrated, in time domain analysis of
HRV, a significant reduction of the total autonomic
system activity in both groups, expressed by progressive
decrease of SDNN value from NIR to IR groups. These
results indicated that the familiarity of type 2 diabetes
mellitus is related to a global reduction of autonomic
nervous system and that the dysautonomia increases if
offsprings are insulin resistant.
In summary, a global reduction and alteration of circa-
dian rhythm of autonomic activity are present in offspring
of type 2 diabetic patients, without and with insulin resist-
ance (figure 2, 3).
A long term observation can answer the question whether
autonomic abnormality precede the occurence of insuline
resistence and play a role in the complex pathogenesis of
the insulin resistance and type 2 diabetes mellitus. Others
studies occurs to explain a possible pathogenetic role of
autonomic dysfunction in the development of insulin
resistance and type 2 diabetes mellitus.
LF value in offsprings of type 2 diabetic patients and control Figure 2
LF value in offsprings of type 2 diabetic patients and 
control. IR: insulin resistant offsprings of type 2 diabetic 
patients, NIR: non insulin resistant offsprings of type 2 dia-
betic patients, LF: low frequency, hours of Holter registra-
tion: 0–6 am= night time, 7–12 am = morning. * p < 0.001 
NIR and IR vs controls, #: p:0.001 IR vs NIR; & p < 0.001 
controlsvs NIR and IR.
Circadian variation of LF in IR, NIR and in control group Figure 3
Circadian variation of LF in IR, NIR and in control 
group. Gray circles: group of non insulin resistant offsprings 
of type 2 diabetic patients; black squares: group of insulin 
resistant offsprings of type 2 diabetic patients; white triangles: 
control group; IR: insulin resistant offsprings of type 2 dia-
betic patients, NIR: non insulin resistant offsprings of type 2 
diabetic patients, LF: low frequency.
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LF/HF value in offsprings of type 2 diabetic patients and  control Figure 4
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and control. IR: insulin resistant offsprings of type 2 diabetic 
patients, NIR: non insulin resistant offsprings of type 2 dia-
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Limitations
A limitation in this study is the use of the HOMA index as
a conventional indicator of insulin resistance. The best
method for assessment of insulin resistance is the glucose
clamp technique, however, the HOMA model has proved
be a robust clinical and epidemiological tool in descrip-
tions of the pathophysiology of diabetes, already quoted
in > 500 publications, it has become one of standard tools
in the armamentarium of the clinical physiologist [23].
Other study are necessary to determine the mechanism
whereby insulin-resistance may be related to autonomic
dysfunction.
List of abbreviations
BMI: body mass index; DM: type 2 diabetes mellitus; HF:
high frequency; HOMA-I: the homeostasis model assess-
ment-index;  HRV: heart rate variability; LF: low fre-
quency; OGTTs: oral glucose tolerance tests; RMS-SD: the
square root of the mean of the sum of the squares of
differences between adjacent NN intervals; SDNN: The
standard deviation of normal-to-normal RR intervals;
WHR: waist-to-hip ratio.
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